Longevity
Deep Dive
Landmark Study Identifies Unique Bile Acid and Steroid 'Fingerprint' in Centenarians Linked to Exceptional Longevity
4 sources · 64d ago
Explainer
The Evidence Pack: How Tavapadon's Phase 3 Data Could Reshape Parkinson's Motor Control
6 sources · 66d ago
Deep Dive
Drug Blocks Aging Protein to Regenerate Lost Cartilage in Mice and Human Samples, Offering Functional Cure for Osteoarthritis
7 sources · 67d ago
More in Longevity
Research BriefGene Therapy
EC Approves First Gene Replacement Therapy for Adults and Older Children with Spinal Muscular Atrophy
Neuromuscular Specialists 39%Patient Advocacy Groups 33%Regulatory & Industry Bodies 28%
4 sources · 67d ago
Deep DiveCellular Reprogramming
First Patient Dosed in Landmark Trial of Systemic Cellular Reprogramming Therapy
Longevity Biotech Industry 45%Cautious Gerontologists 35%Regulatory & Safety Monitors 20%
5 sources · 67d ago
Research BriefMetabolic Health
The Evidence Pack: How the First Once-Weekly Insulin is Rewriting Type 2 Diabetes Management
Endocrinologists & Clinicians 40%Drug Safety Regulators 35%Pharmaceutical Developers 25%
3 sources · 71d ago
Deep DiveLongevity Medicine
Major Human Trial Launches to Test Three FDA-Approved Drugs for Healthspan and New Regulatory Endpoint
Geroscience Researchers 40%Regulatory Pragmatists 35%Clinical Skeptics 25%
5 sources · 72d ago
Research BriefNetwork Medicine
The Evidence Pack: How a Common Nasal Spray Emerged as a Computational Anti-Aging Candidate
Network Medicine Researchers 40%Clinical Pharmacologists 40%Geroscience Advocates 20%
4 sources · 72d ago
ExplainerSmoking Cessation
FDA Nears Approval of Cytisinicline, the First New Non-Nicotine Smoking Cessation Pill in Two Decades
Addiction Medicine Specialists 40%Public Health Advocates 35%Pharmacological Researchers 25%
6 sources · 72d ago
Research BriefHealthspan Metrics
The Evidence Pack: How Recent US Life Expectancy Gains Are Translating Entirely Into Healthy Years
Biogerontologists 40%Public Health Economists 30%Health Equity Advocates 30%
3 sources · 73d ago
ExplainerObesity Medicine
FDA Approves CagriSema, the First Combination GLP-1 and Amylin Therapy for Weight Loss
Clinical Endocrinologists 40%Metabolic Researchers 35%Health Economists 25%
4 sources · 73d ago
Research BriefLongevity Science
The Evidence Pack: How GLP-1 Receptor Agonists Reduce Biological Age on Epigenetic Clocks
Longevity Medicine Advocates 40%Clinical Skeptics 35%Trial Investigators 25%
4 sources · 74d ago
ExplainerPeptide Therapy
The Evidence Pack: How the Anti-Aging Peptide Epitalon Works as it Clears a Major FDA Hurdle
Longevity Researchers 40%Regulatory Agencies 35%Endocrinologists 25%
6 sources · 74d ago
Deep DiveGeroscience
The Evidence Pack: How Three FDA-Approved Drugs Are Being Tested to Slow Human Aging
Geroscience Researchers 45%Clinical Skeptics 35%Public Health Advocates 20%
6 sources · 74d ago
Deep DiveCellular Reprogramming
The Evidence Pack: How Partial Cellular Reprogramming is Entering Human Trials to Reverse Vision Loss
Longevity Researchers 40%Clinical Ophthalmologists 35%Safety & Bioethics Monitors 25%
5 sources · 74d ago